UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 271

Sortiert nach

Drug-induced scleroderma-like lesion

Allergology international, 2022-04, Vol.71 (2), p.163-168

Hamaguchi, Yasuhito

2022

Link zum Volltext

Verfügbarkeit prüfen

Autoantibody profiles in systemic sclerosis: Predictive value for clinical evaluation and prognosis

Journal of dermatology, 2010-01, Vol.37 (1), p.42-53

HAMAGUCHI, Yasuhito

2010

Link zum Volltext

Verfügbarkeit prüfen

Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies

Clinical rheumatology, 2020-11, Vol.39 (11), p.3489-3497

2020

Link zum Volltext

Verfügbarkeit prüfen

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome

PloS one, 2013-04, Vol.8 (4), p.e60442-e60442

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting cytokines and potentiality of JAK–STAT inhibition in systemic sclerosis

Journal of cutaneous immunology and allergy, 2023-02, Vol.6 (1), p.4-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Long‐term changes in nail fold capillary abnormalities and serum fibroblast growth factor 23 levels in dermatomyositis patients with anti‐melanoma differentiating antigen 5 antibody

Journal of dermatology, 2021-01, Vol.48 (1), p.106-109

2021

Link zum Volltext

Verfügbarkeit prüfen

Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease

Journal of dermatology, 2019-12, Vol.46 (12), p.1190-1196

2019

Link zum Volltext

Verfügbarkeit prüfen

Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod

Scientific reports, 2019-01, Vol.9 (1), p.658-658, Article 658

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of anti-OJ antibody detection assays between an immunoprecipitation assay and line blot assay

Modern rheumatology, 2017-05, Vol.27 (3), p.551-552

2017

Link zum Volltext

Verfügbarkeit prüfen

Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies

PloS one, 2016-05, Vol.11 (5), p.e0154746-e0154746

2016

Link zum Volltext

Verfügbarkeit prüfen

Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease

Blood, 2013-04, Vol.121 (16), p.3274-3283

2013

Link zum Volltext

Verfügbarkeit prüfen

Anti‐transcriptional intermediary factor 1‐γ antibody as a biomarker in patients with dermatomyositis

Journal of dermatology, 2020-01, Vol.47 (1), p.64-68

2020

Link zum Volltext

Verfügbarkeit prüfen

B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells

Journal of allergy and clinical immunology, 2013-06, Vol.131 (6), p.1674-1682.e9

2013

Link zum Volltext

Verfügbarkeit prüfen

Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients

Modern rheumatology, 2020-07, Vol.30 (4), p.681-686

2020

Link zum Volltext

Verfügbarkeit prüfen

A case of IgG4‐related skin disease with plaques on the lower legs

Journal of cutaneous immunology and allergy, 2023-10, Vol.6 (5), p.183-185

2023

Link zum Volltext

Verfügbarkeit prüfen

Maintenance of Long-Lived Plasma Cells and Serological Memory Despite Mature and Memory B Cell Depletion during CD20 Immunotherapy in Mice

The Journal of immunology (1950), 2008-01, Vol.180 (1), p.361-371

2008

Link zum Volltext

Verfügbarkeit prüfen

The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6133

2024

Link zum Volltext

Verfügbarkeit prüfen

Adipose‐derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models

International journal of rheumatic diseases, 2020-02, Vol.23 (2), p.216-225

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc‐related autoantibodies: A single‐center retrospective study

International journal of rheumatic diseases, 2020-08, Vol.23 (9), p.1219-1225

2020

Link zum Volltext

Verfügbarkeit prüfen

A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase–Akt pathway activation

Journal of allergy and clinical immunology, 2016-10, Vol.138 (4), p.1170-1182.e9

2016

Link zum Volltext

Verfügbarkeit prüfen

Progressive Aortic Calcification as a Complication of Dermatomyositis

Circulation Journal, 2019/08/23, Vol.83(9), pp.1972

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonia: The relation between the disease activity and the serum interleukin‐6 level

Journal of dermatology, 2017-10, Vol.44 (10), p.1164-1167

2017

Link zum Volltext

Verfügbarkeit prüfen

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance

Science advances, 2018-07, Vol.4 (7), p.eaas9944-eaas9944

2018

Link zum Volltext

Verfügbarkeit prüfen

A role for FcγRIIB in the development of murine bleomycin-induced fibrosis

Journal of dermatological science, 2021-12, Vol.104 (3), p.201-209

2021

Link zum Volltext

Verfügbarkeit prüfen

Cytokine‐producing B‐cell balance associates with skin fibrosis in patients with systemic sclerosis

Journal of dermatology, 2022-10, Vol.49 (10), p.1012-1019

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 271

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(236)

Publikationsform

Sprache

Englisch
(260)
Japanisch
(60)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Drug-induced scleroderma-like lesion

Autoantibody profiles in systemic sclerosis: Predictive value for clinical evaluation and prognosis

Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome

Targeting cytokines and potentiality of JAK–STAT inhibition in systemic sclerosis

Long‐term changes in nail fold capillary abnormalities and serum fibroblast growth factor 23 levels in dermatomyositis patients with anti‐melanoma differentiating antigen 5 antibody

Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease

Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod

Comparison of anti-OJ antibody detection assays between an immunoprecipitation assay and line blot assay

Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies

Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease

Anti‐transcriptional intermediary factor 1‐γ antibody as a biomarker in patients with dermatomyositis

B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells

Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients

A case of IgG4‐related skin disease with plaques on the lower legs

Maintenance of Long-Lived Plasma Cells and Serological Memory Despite Mature and Memory B Cell Depletion during CD20 Immunotherapy in Mice

The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis

Adipose‐derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models

Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc‐related autoantibodies: A single‐center retrospective study

A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase–Akt pathway activation

Progressive Aortic Calcification as a Complication of Dermatomyositis

Clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonia: The relation between the disease activity and the serum interleukin‐6 level

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance

A role for FcγRIIB in the development of murine bleomycin-induced fibrosis

Cytokine‐producing B‐cell balance associates with skin fibrosis in patients with systemic sclerosis

Suchergebnisse filtern